Probable Invasive Pulmonary Trichosporonosis in a Diabetic Patient

Tsai, Ming‐Ju; Chang, Wei‐An; Tsai, Kun-Bow; Chen, Huang‐Chi; Hwang, Jhi-Jhu; Huang, Ming‐Shyan

doi:10.1164/rccm.201101-0144im

Cited by 2 publications

(1 citation statement)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present case, the patient showed good response to luconazole therapy. Other studies have also shown similar indings in invasive pulmonary infection [16], invasive Urinary Tract Infection (UTI) and nosocomial UTI caused by T. asahii [17]. However, another study also showed that diabetic patients with disseminated Trichosporonosis did not respond to luconazole therapy and showed remarkable recovery after combination therapy of luconazole and amphotericin B [18].…”

Section: Seven Species Including T Asahii T Asteroides T Cutaneumentioning

confidence: 73%

A rare case of recurrent urinary tract infection due to Trichosporon species in an immune-competent diabetic female patient

Adhikari¹,

Saud²,

Paudel³

et al. 2019

Arch Case Rep

View full text Add to dashboard Cite

show abstract

Section: Seven Species Including T Asahii T Asteroides T Cutaneumentioning

confidence: 73%

A rare case of recurrent urinary tract infection due to Trichosporon species in an immune-competent diabetic female patient

Adhikari¹,

Saud²,

Paudel³

et al. 2019

Arch Case Rep

View full text Add to dashboard Cite

show abstract

Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen

2016

View full text Add to dashboard Cite

Objectives: This review aimed to better depict the clinical features and address the issue of therapeutic management of Trichosporon deep-seated infections.Methods: We comprehensively reviewed the cases of invasive Trichosporon infection reported in the literature from 1994 (date of taxonomic modification) to 2015. Data from antifungal susceptibility testing (AST) studies were also analyzed.Results: Two hundred and three cases were retained and split into four groups: homeopathy (n = 79), other immunodeficiency conditions (n = 41), miscellaneous (n = 58) and newborns (n = 25). Trichosporon asahii was the main causative species (46.7%) and may exhibit cross-resistance to different antifungal classes. The unfavorable outcome rate was at 44.3%. By multivariate analysis, breakthrough infection (OR 2.45) was associated with unfavorable outcome, whilst the use of an azole-based therapy improved the prognosis (OR 0.16). Voriconazole-based treatment was associated with favorable outcome in hematological patients (73.6 vs. 41.8%; p = 0.016). Compiled data from AST demonstrated that (i) T. asahii exhibits the highest MICs to amphotericin B and (ii) voriconazole has the best in vitro efficacy against clinical isolates of Trichosporon spp.Conclusions: Trichosporon infection is not only restricted to hematological patients. Analysis of compiled data from AST and clinical outcome support the use of voriconazole as first line therapy.

show abstract

Probable Invasive Pulmonary Trichosporonosis in a Diabetic Patient

Cited by 2 publications

References 2 publications

A rare case of recurrent urinary tract infection due to Trichosporon species in an immune-competent diabetic female patient

A rare case of recurrent urinary tract infection due to Trichosporon species in an immune-competent diabetic female patient

Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen

Contact Info

Product

Resources

About